Purpose: To evaluate the role of optical coherence tomography (OCT)-based angiography (OCTA) in the diagnosis and monitoring of pediatric patients with retinal artery occlusion (RAO). Material and Methods: This retrospective study was conducted at the Department of Ophthalmology, The Children's Memorial Health Institute, in Warsaw between March 2015 and May 2016. Every patient underwent a complete ophthalmological examination. The diagnosis of the disease was based on fundus examination and fluorescein angiography (FA). OCT and OCTA were performed at baseline and every follow-up visit. Results: Four patients (4 eyes) (2 boys/2 girls, age 8-16 years) with RAO were enrolled in the study. In all cases, initial OCTA images revealed typical ischemic changes in superficial and deep retinal capillary plexuses. Follow-up OCTA revealed increasing areas of ischemia in the RAO region and persistent narrowing of the arteries. The loss of capillary network and the darker, smooth background due to ischemia were visible on OCTA images. Conclusions: OCTA enables clear visualization of progressive impairment of the retinal vascular perfusion in children with RAO and may be an alternative to the standard FA. Further studies are needed to confirm our results and establish the role of OCTA in pediatric patients.

Keywords:
Optical coherence tomography-based angiography, Retinal artery occlusion, Branch retinal artery occlusion, Central retinal artery occlusion
1.
Coban-Karatas M, Erol I, Ozkale Y, Yazici N: Central retinal artery occlusion in a 13-year-old child as a presenting sign of hyperhomocysteinemia together with high lipoprotein(a) level. Pediatr Neurol 2013;49:138-140.
2.
Saliba M, Pelosse B, Momtchilova M, Laroche L: Susac syndrome and ocular manifestation in a 14-year-old-girl. J Fr Ophthalmol 2007;30:1017-1022.
3.
Ehmann D, Riyaz R, Greve M: Central retinal artery occlusion in a child with Parry-Romberg syndrome. Can J Ophthalmol 2014;49:e9-e10.
4.
de Castro-Abeger AH, de Carlo TE, Duker JS, Baumal CR: Optical coherence tomography angiography compared to fluorescein angiography in branch retinal artery occlusion. Ophthalmic Surg Lasers Imaging Retina 2015;46:1052-1054.
5.
Bonini Filho MA, Adhi M, de Carlo TE, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Kuehlewein L, Sadda SR, Sarraf D, Duker JS, Waheed NK: Optical coherence tomography angiography in retinal artery occlusion. Retina 2015;35:2339-2346.
6.
Mendis KR, Balaratnasingam C, Yu P, Barry CJ, McAllister IL, Cringle SJ, Yu DY: Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail. Invest Ophthalmol Vis Sci 2010;51:5864-5869.
7.
Lee AY, Zhang Q, Baughman DM, Mudumbai R, Wang RK, Lee CS: Evaluation of bilateral central retinal artery occlusions with optical coherence tomography-based microangiography: a case report. J Med Case Rep 2016;10:307.
8.
Durbin MK, An L, Shemonski ND, Soares M, Santos T, Lopes M, Neves C, Cunha-Vaz J: Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol 2017;135:370-376.
9.
Mastropasqua R, Toto L, Senatore A, D'Uffizi A, Neri P, Mariotti C, Maccarone MT, Di Antonio L: Optical coherence tomography angiography findings in Susac's syndrome: a case report. Int Ophthalmol DOI: 10.1007/s10792-017-0653-9.
10.
Damento G, Chen MH, Leng T: Spectral-domain optical coherence tomography angiography of central retinal artery occlusion. Ophthalmic Surg Lasers Imaging Retina 2016;47:467-470.
11.
Hautz W, Gołębiewska J, Kocyła-Karczmarewicz B: Optical coherence tomography and optical coherence tomography angiography in monitoring Coats' disease. J Ophthalmol 2017;2017:7849243.
12.
Fortunato M, Turtoro A, Cennamo G: Optical coherence tomography angiography in children with Leber-Coats disease. Ophthalmic Res 2017;58:185-187.
13.
Stanga PE, Papayannis A, Tsamis E, Chwiejczak K, Stringa F, Jalil A, Cole T, Biswas S: Swept-source optical coherence tomography angiography of paediatric macular diseases. Dev Ophthalmol 2016;56:166-173.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.